The world’s best-selling drug is in line for cheaper competition — eventually
(By Damian Garde for ST A T) T he Food and Drug Administration on Friday approved a lower-cost version of
Read More
Part D/Prescription Drugs
Why Pharmaceutical Companies Like Mylan Charge So Much for Drugs
(By Melissa Quinn for The Daily Signal) In the wake of news that pharmaceutical company Mylan quadrupled the price of
Read MoreFreeze-dried drug factories could make a slew of medicines — just add water
(By Eric Boodman for ST A T) T he contraption looks and sounds like a washing machine: a rumbling box
Read MoreThe curious case of the $9,500 skin gel
(By Ed Silverman for ST A T) E ven in an age when prescription drugs are increasingly expensive, a $9,500
Read MoreIt’s time to call the opioid epidemic a public health emergency
(By Benjamin Bearnot & Mark Eisenberg for ST A T) L ast month, the Obama administration declared a public health
Read MoreThe drug industry might finally have an answer for migraines
(By Damian Garde for ST A T) It often starts with the aura. Zig-zagging lines come into view, everyday light
Read MoreChanges to UnitedHealth Drug Formulary List Includes Biosimilar Drugs
On Wednesday, UnitedHealth announced their proposed changes to their drug formulary list which include excluding Sanofi’s insulin Lantus and Amgen’s
Read MoreValeant avoids double-digit price hikes with 9.9 percent increases
(By Ed Silverman for ST A T) In response to intensifying criticism over drug prices, Allergan chief executive Brent Saunders
Read MoreColorado is latest state to be sued for restricting access to hepatitis C drugs
(By Ed Silverman for ST A T) Y ou can add Colorado to the list of states being sued 1
Read MoreSecret trove reveals bold ‘crusade’ to make OxyContin a blockbuster
(By David Armstrong for ST A T) W ELCH, W.Va. — The pharmaceutical sales representatives from health care giant Abbott
Read More